RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      KCI등재 SCIE SCOPUS

      Emergence of optrA-Mediated Linezolid-Nonsusceptible Enterococcus faecalis in a Tertiary Care Hospital

      한글로보기

      https://www.riss.kr/link?id=A106912202

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract)

      This study investigated resistance mechanisms and epidemiology of emerging linezolid-nonsusceptible Enterococcus faecalis (LNSEF) in a tertiary care hospital. LNSEF isolated from clinical samples were collected from November 2017 to June 2019. The isolates were investigated for linezolid resistance and the associated molecular mechanisms, including mutations of 23S rRNA domain V and acquisition of the cfr or optrA resistance gene. We used pulsed-field gel electrophoresis (PFGE) and multilocus sequence typing for the molecular typing of the isolates. Among 4,318 E. faecalis isolates, 10 (0.23%) were linezolid-nonsusceptible. All LNSEF isolates were optrA-positive and cfr-negative. Of these isolates, five were sequence type (ST) 476, two ST585, one ST16, one ST16-like, and one ST480. Six LNSEF isolates obtained in the first year clustered to three types in the PFGE analysis: two ST476 isolates of type A, two ST585 isolates of type B, and two ST16 or ST16-like isolates of type C. Seven cases were of community-onset and three were hospital acquired, but total of eight were healthcare-associated including five community-onset. None of the patients had a history of linezolid treatment, and in one patient, we detected linezolid-susceptible E. faecalis one month before LNSEF detection. In conclusion, heterogenous clones of optrA-positive LNSEF emerged in the hospital mainly via community-onset.
      번역하기

      This study investigated resistance mechanisms and epidemiology of emerging linezolid-nonsusceptible Enterococcus faecalis (LNSEF) in a tertiary care hospital. LNSEF isolated from clinical samples were collected from November 2017 to June 2019. The iso...

      This study investigated resistance mechanisms and epidemiology of emerging linezolid-nonsusceptible Enterococcus faecalis (LNSEF) in a tertiary care hospital. LNSEF isolated from clinical samples were collected from November 2017 to June 2019. The isolates were investigated for linezolid resistance and the associated molecular mechanisms, including mutations of 23S rRNA domain V and acquisition of the cfr or optrA resistance gene. We used pulsed-field gel electrophoresis (PFGE) and multilocus sequence typing for the molecular typing of the isolates. Among 4,318 E. faecalis isolates, 10 (0.23%) were linezolid-nonsusceptible. All LNSEF isolates were optrA-positive and cfr-negative. Of these isolates, five were sequence type (ST) 476, two ST585, one ST16, one ST16-like, and one ST480. Six LNSEF isolates obtained in the first year clustered to three types in the PFGE analysis: two ST476 isolates of type A, two ST585 isolates of type B, and two ST16 or ST16-like isolates of type C. Seven cases were of community-onset and three were hospital acquired, but total of eight were healthcare-associated including five community-onset. None of the patients had a history of linezolid treatment, and in one patient, we detected linezolid-susceptible E. faecalis one month before LNSEF detection. In conclusion, heterogenous clones of optrA-positive LNSEF emerged in the hospital mainly via community-onset.

      더보기

      참고문헌 (Reference)

      1 Jung J, "The pitfall of cohort isolation in an outbreak of linezolid-resistant, vancomycin-resistant enterococci" 25 : 1568-1569, 2019

      2 Huang J, "Retrospective analysis of genome sequences revealed the wide dissemination of optrA in Gram-positive bacteria" 72 : 614-616, 2017

      3 Lee SM, "Resistance mechanisms of linezolid-nonsusceptible enterococci in Korea: low rate of 23S rRNA mutations in Enterococcus faecium" 66 : 1730-1735, 2017

      4 Bender JK, "Rapid emergence of highly variable and transferable oxazolidinone and phenicol resistance gene optrA in German Enterococcus spp. clinical isolates" 52 : 819-827, 2018

      5 Cui L, "Nationwide surveillance of novel oxazolidinone resistance gene optrA in Enterococcus isolates in China from 2004 to 2014" 60 : 7490-7493, 2016

      6 Ruoyi Hua, "Molecular Epidemiology and Mechanisms of 43 Low-Level Linezolid-Resistant Enterococcus faecalis Strains in Chongqing, China" 대한진단검사의학회 39 (39): 36-42, 2019

      7 Mendes RE, "Linezolid update: stable in vitro activity following more than a decade of clinical use and summary of associated resistance mechanisms" 17 : 1-12, 2014

      8 Tenover FC, "Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing" 33 : 2233-2239, 1995

      9 Pfaller MA, "Five-year summary of in vitro activity and resistance mechanisms of linezolid against clinically important Gram-positive cocci in the United States from the LEADER surveillance program (2011 to 2015)" 61 : e00609-e00617, 2017

      10 Bae HG, "First report of a linezolid- and vancomycin-resistant Enterococcus faecium strain in Korea" 38 : 383-386, 2006

      1 Jung J, "The pitfall of cohort isolation in an outbreak of linezolid-resistant, vancomycin-resistant enterococci" 25 : 1568-1569, 2019

      2 Huang J, "Retrospective analysis of genome sequences revealed the wide dissemination of optrA in Gram-positive bacteria" 72 : 614-616, 2017

      3 Lee SM, "Resistance mechanisms of linezolid-nonsusceptible enterococci in Korea: low rate of 23S rRNA mutations in Enterococcus faecium" 66 : 1730-1735, 2017

      4 Bender JK, "Rapid emergence of highly variable and transferable oxazolidinone and phenicol resistance gene optrA in German Enterococcus spp. clinical isolates" 52 : 819-827, 2018

      5 Cui L, "Nationwide surveillance of novel oxazolidinone resistance gene optrA in Enterococcus isolates in China from 2004 to 2014" 60 : 7490-7493, 2016

      6 Ruoyi Hua, "Molecular Epidemiology and Mechanisms of 43 Low-Level Linezolid-Resistant Enterococcus faecalis Strains in Chongqing, China" 대한진단검사의학회 39 (39): 36-42, 2019

      7 Mendes RE, "Linezolid update: stable in vitro activity following more than a decade of clinical use and summary of associated resistance mechanisms" 17 : 1-12, 2014

      8 Tenover FC, "Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing" 33 : 2233-2239, 1995

      9 Pfaller MA, "Five-year summary of in vitro activity and resistance mechanisms of linezolid against clinically important Gram-positive cocci in the United States from the LEADER surveillance program (2011 to 2015)" 61 : e00609-e00617, 2017

      10 Bae HG, "First report of a linezolid- and vancomycin-resistant Enterococcus faecium strain in Korea" 38 : 383-386, 2006

      11 Cai J, "Faecal carriage of optrA-positive enterococci in asymptomatic healthy humans in Hangzhou, China" 25 : 630.e1-636.e6, 2019

      12 Deshpande LM, "Evolving oxazolidinone resistance mechanisms in a worldwide collection of enterococcal clinical isolates: results from the SENTRY Antimicrobial Surveillance Program" 73 : 2314-2322, 2018

      13 Sassi M, "Emergence of optrA-mediated linezolid resistance in enterococci from France, 2006-16" 74 : 1469-1472, 2019

      14 Zhou W, "Distribution of the optrA gene in Enterococcus isolates at a tertiary care hospital in China" 17 : 180-186, 2019

      15 Na SH, "Detection of oxazolidinone and phenicol resistant enterococcal isolates from duck feces and carcasses" 293 : 53-59, 2019

      16 Argudín MA, "Detection of optrA-positive enterococci clinical isolates in Belgium" 38 : 985-987, 2019

      17 Tamang MD, "Detection of novel oxazolidinone and phenicol resistance gene optrA in enterococcal isolates from food animals and animal carcasses" 201 : 252-256, 2017

      18 Wang Y, "A novel gene, optrA, that confers transferable resistance to oxazolidinones and phenicols and its presence in Enterococcus faecalis and Enterococcus faecium of human and animal origin" 70 : 2182-2190, 2015

      19 Zhang Y, "A high incidence and coexistence of multiresistance genes cfr and optrA among linezolid-resistant enterococci isolated from a teaching hospital in Wenzhou, China" 37 : 1441-1448, 2018

      더보기

      동일학술지(권/호) 다른 논문

      동일학술지 더보기

      더보기

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      인용정보 인용지수 설명보기

      학술지 이력

      학술지 이력
      연월일 이력구분 이력상세 등재구분
      2023 평가예정 해외DB학술지평가 신청대상 (해외등재 학술지 평가)
      2020-01-01 평가 등재학술지 유지 (해외등재 학술지 평가) KCI등재
      2012-05-21 학술지명변경 한글명 : The Korean Journal of Laboratory Medicine -> Annals of Laboratory Medicine
      외국어명 : The Korean Journal of Laboratory Medicine -> Annals of Laboratory Medicine
      KCI등재
      2011-01-01 평가 학술지 분리 (기타) KCI등재
      2010-06-29 학술지명변경 한글명 : 대한진단검사의학회지 -> The Korean Journal of Laboratory Medicine KCI등재
      2009-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2007-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2005-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2002-01-01 평가 등재학술지 선정 (등재후보2차) KCI등재
      1999-07-01 평가 등재후보학술지 선정 (신규평가) KCI등재후보
      더보기

      학술지 인용정보

      학술지 인용정보
      기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
      2016 1.51 0.18 1.15
      KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
      0.91 0.81 0.458 0.08
      더보기

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼